Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis
General Info
Coverage type
Global
Time period covered
January, 2017 - December, 2021
Data type
Scientific literature
Keywords
Citation
Journal
Front Oncol
Pages
1044327
Publication year
2023
Suggested citation
Yang B, Wang B, Chen Y, Wan N, Xie F, Yang N, Lu L, Xiao W, Yuan J, Li J, Xie B, Ji B. Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis. Front Oncol. 2023; 13(1044327): 1044327.